Marriage Counselors in Hurst, TX Accepting Medicare

6 Marriage Counselors found. Showing 1 - 6

David E Prysock Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 4825 Wedgeview Dr, Hurst, TX 76053 Phone: 214-934-0398

Amanda Harvey, LMFT-A Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Grapevine Hwy Ste 215, Hurst, TX 76054 Phone: 817-849-2360

Caitlyn Simmons Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1726 Chadwick Ct Ste 200, Hurst, TX 76054 Phone: 817-500-6427

Shauna Nicole Sears-cyprian, MS, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 10032 Daly Dr, Hurst, TX 76053 Phone: 916-813-2551

Debra Renea Taylor-smith, M.S. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Grapevine Hwy, Suite 340, Hurst, TX 76054 Phone: 817-307-6446

Michael Scott Hardgrove, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1405 Wreyhill Dr, Hurst, TX 76053 Phone: 817-330-9351

News Archive

Specific and sensitive biomarker in the blood predicts symptomatic COVID-19 infection

Researchers remain perplexed as to why some patients infected with SARS-CoV-2, the virus responsible for COVID-19, remain asymptomatic while other patients develop severe disease symptoms.

Cancer survivors become advocates for other cancer patients

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society.

iCOquit®: The innovation aiding remote Stop Smoking Services during COVID-19

The new Bluetooth® CO monitor from Bedfont® Scientific Ltd. has helped Stop Smoking Clinics to continue giving essential advice to its patients through remote CO monitoring.

Pharmasset prices underwritten public offering of 3,300,000 shares of common stock

Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.

New findings may help identify treatments for diabetes and hyperinsulinemia

By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion. The mechanism involves a protein called ankyrin, which UI researchers previously linked to potentially fatal human heart arrhythmias.

Read more Medical News

› Verified 2 days ago